![IJMS | Free Full-Text | Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis IJMS | Free Full-Text | Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis](https://pub.mdpi-res.com/ijms/ijms-22-07470/article_deploy/html/images/ijms-22-07470-g002.png?1626146869)
IJMS | Free Full-Text | Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures | PLOS ONE
![Frontiers | Higher Incidence of B Cell Malignancies in Primary Immunodeficiencies: A Combination of Intrinsic Genomic Instability and Exocytosis Defects at the Immunological Synapse Frontiers | Higher Incidence of B Cell Malignancies in Primary Immunodeficiencies: A Combination of Intrinsic Genomic Instability and Exocytosis Defects at the Immunological Synapse](https://www.frontiersin.org/files/Articles/581119/fimmu-11-581119-HTML/image_m/fimmu-11-581119-g001.jpg)
Frontiers | Higher Incidence of B Cell Malignancies in Primary Immunodeficiencies: A Combination of Intrinsic Genomic Instability and Exocytosis Defects at the Immunological Synapse
![PDF) MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide | Darren Jones - Academia.edu PDF) MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide | Darren Jones - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/80245458/mini_magick20220205-12611-12ojjl2.png?1644063476)
PDF) MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide | Darren Jones - Academia.edu
![Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma - Cytotherapy Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma - Cytotherapy](https://www.isct-cytotherapy.org/cms/attachment/bee9f53b-aef6-47a7-a53a-e24e20f404b0/gr1_lrg.jpg)